NIH-funded research U01 cooperative agreement

Gait speed from wearable sensors to guide ALS trials

Official title: Clinical and Usability Validation of Gait Velocity (SV95C) Measured from Wearable Digital Sensors

Funded at Massachusetts General Hospital · NIH-11622545 · Data updated 2026-11-12

A patient-friendly look at using wearable sensors to measure how fast people with ALS walk, to help run better ALS trials.

More Gait research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$878,203
NIH project number1U01FD009015-01
Project IDNIH-11622545 on NIH RePORTER

Who could benefit from this research

Could help

Adults with amyotrophic lateral sclerosis (ALS) who are potential candidates for participation in clinical trials.

Less likely to help

Patients not able to participate in wearables-based assessments or with contraindications to wearable sensors may not benefit.

What this research studies

This project tests a new wearable-based measure of walking speed (SV95C) in people with ALS to see if it reflects meaningful changes during treatment. It compares this gait metric to traditional ALS scales and walking tests, and it looks at how patients experience and respond to the measure. The goal is to determine if SV95C can serve as a reliable, patient-friendly endpoint in future ALS trials, and to gather user feedback on its usefulness in clinical care. The study emphasizes real-world wearables, ease of use, and relevance to patients’ daily function.

Why it matters

Potential benefit: If successful, patients may benefit from more accurate and meaningful endpoints in ALS trials that could speed up the development of effective therapies.

How similar studies have gone: Wearable-derived gait metrics have shown promise in other neuromuscular conditions and are being explored in ALS; this study advances to clinical trial readiness for ALS.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Berry, James Dale — Massachusetts General Hospital
  • Study coordinator: Berry, James Dale

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.